These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4604281)

  • 1. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of antibody to each component of Clostridium botulinum type E progenitor toxin.
    Sakaguchi G; Sakaguchi S
    Jpn J Med Sci Biol; 1973 Dec; 26(5):187-95. PubMed ID: 4601357
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
    Johnson HM; Brenner K; Angelotti R; Hall HE
    J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological specificity of type E botulinal toxin.
    Johnson HM; Smith BG; Lewis KH
    Proc Soc Exp Biol Med; 1971 Jul; 137(3):973-6. PubMed ID: 4997865
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of Clostridium boltulinum toxins using passive hemagglutination].
    Franke F
    Zentralbl Veterinarmed B; 1974 Sep; 21(9):660-76. PubMed ID: 4619737
    [No Abstract]   [Full Text] [Related]  

  • 8. [NONSPECIFIC REACTION OF INDIRECT HEMAGGLUTINATION IN DETECTION OF BOTULISM TOXINS IN FOOD PRODUCTS].
    BULATOVA TI
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jan; 41():96-101. PubMed ID: 14182401
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antigenic structure of Cl. botulinum types E and F].
    Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):28-32. PubMed ID: 4920529
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological difference between the toxin of a progeolytic strain and that of a nonproteolytic strain of Clostridium botulinum type B.
    Shimizu T; Kondo H
    Jpn J Med Sci Biol; 1973 Dec; 26(5):269-71. PubMed ID: 4601358
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic and chromatographic identity of two apparently distinct toxins of Clostridium botulinum type A.
    Hauschild AH; Hilsheimer R
    Can J Microbiol; 1969 Oct; 15(10):1129-32. PubMed ID: 4905857
    [No Abstract]   [Full Text] [Related]  

  • 12. The partial reactivation of formalin-inactivated Clostridium botulinum type C toxin.
    MARTY EW
    Am J Vet Res; 1961 Jul; 22():770-4. PubMed ID: 13767602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemagglutinin specificity of Cl. botulinum types A, B, and F in reaction with erythrocytes of various animals].
    Blagoveshchenskii BA; Ivanova LG; Khatuntseva NV; Kliucheva VV; Nikitina AA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jul; (7):47-51. PubMed ID: 56111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the passive hemagglutination inhibition reaction for the purpose of determining the antigenic activity of anatoxins in vitro].
    Vorontsov IV; Moshiashvili IIa; Severtsova MK; Besova SA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):62-6. PubMed ID: 375637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research in vitro on toxigenesis of Cl. tetani and Cl. botulinum].
    D'ARCA SIMONETTI A
    Nuovi Ann Ig Microbiol; 1959; 10():342-58. PubMed ID: 13813594
    [No Abstract]   [Full Text] [Related]  

  • 20. Phagocytosis of staphylococci by mouse leukocytes in the presence of botulinum toxin.
    FREEMAN NL
    J Bacteriol; 1961 Jan; 81(1):156-7. PubMed ID: 13701643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.